Keratoacanthomas associated with imatinib mesylate

Authors

  • Yevgeniy Balagula Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  • Klaus J. Busam Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  • Richard D. Carvajal Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  • Jedd D. Wolchok Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  • Patricia L. Myskowski Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

DOI:

https://doi.org/10.3109/0284186X.2010.537690

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-05-01

How to Cite

Balagula, Y., Busam, K. J., Carvajal, R. D., Wolchok, J. D., & Myskowski, P. L. (2011). Keratoacanthomas associated with imatinib mesylate. Acta Oncologica, 50(4), 593–595. https://doi.org/10.3109/0284186X.2010.537690